Citius Oncology, Inc. (CTOR) stock
CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.56+0.01 (+1.79%)
Close on Nov 18, 2026Market cap $51.83MP/E –Yield –
Citius Oncology shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Citius Oncology's shares outstanding was 108M at Jun 30, 2026. For fiscal 2025 it was 73M, up 281.0% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 73M | +281.0% |
| FY2022 | Dec 31, 2022 | 19M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | 108M | +50.8% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | 100M | +39.8% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | 87M | +22.2% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | 78M | +531.0% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | 72M | +232.8% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | 72M | +232.8% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | 72M | +189.4% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | 12M | -42.2% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | 22M | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | 22M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | 25M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | 22M | – |
See a number that looks wrong?